Cardlytics, Inc. (NASDAQ:CDLX) Receives $6.92 Consensus Price Target from Brokerages

Shares of Cardlytics, Inc. (NASDAQ:CDLX) have earned a consensus rating of “Hold” from the seven brokerages that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a strong buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $6.92.

Several brokerages recently issued reports on CDLX. Craig Hallum upgraded Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. Evercore ISI started coverage on Cardlytics in a report on Friday, October 11th. They issued an “in-line” rating and a $4.00 price objective for the company. Finally, Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a report on Thursday, November 7th.

Insider Transactions at Cardlytics

In other news, CFO Alexis Desieno sold 25,118 shares of the firm’s stock in a transaction dated Friday, November 15th. The shares were sold at an average price of $3.43, for a total transaction of $86,154.74. Following the completion of the sale, the chief financial officer now owns 116,481 shares in the company, valued at approximately $399,529.83. This trade represents a 17.74 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Amit Gupta sold 22,607 shares of the company’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $3.85, for a total transaction of $87,036.95. Following the completion of the transaction, the chief executive officer now owns 178,519 shares in the company, valued at approximately $687,298.15. This trade represents a 11.24 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 69,007 shares of company stock worth $251,297. 4.40% of the stock is owned by company insiders.

Institutional Trading of Cardlytics

Several hedge funds have recently added to or reduced their stakes in CDLX. Sanctuary Advisors LLC acquired a new stake in Cardlytics in the 3rd quarter worth about $82,000. Barclays PLC increased its holdings in shares of Cardlytics by 223.9% during the third quarter. Barclays PLC now owns 58,026 shares of the company’s stock worth $186,000 after purchasing an additional 40,112 shares during the period. Geode Capital Management LLC raised its position in shares of Cardlytics by 7.5% in the third quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock valued at $3,371,000 after buying an additional 73,484 shares in the last quarter. Quadrature Capital Ltd bought a new stake in shares of Cardlytics in the third quarter valued at approximately $63,000. Finally, RBF Capital LLC grew its position in Cardlytics by 311.9% during the third quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock worth $1,562,000 after buying an additional 369,620 shares in the last quarter. 68.10% of the stock is owned by institutional investors and hedge funds.

Cardlytics Stock Down 1.4 %

Cardlytics stock opened at $3.44 on Friday. Cardlytics has a fifty-two week low of $2.89 and a fifty-two week high of $20.52. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. The firm has a market capitalization of $174.83 million, a price-to-earnings ratio of -0.56 and a beta of 1.53. The company’s 50 day simple moving average is $3.90 and its 200 day simple moving average is $4.78.

Cardlytics (NASDAQ:CDLX) last announced its quarterly earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.18. Cardlytics had a negative net margin of 93.55% and a negative return on equity of 110.67%. The company had revenue of $67.06 million for the quarter, compared to analysts’ expectations of $57.77 million. During the same period last year, the firm posted ($0.26) earnings per share. The business’s quarterly revenue was down 15.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that Cardlytics will post -1.52 EPS for the current year.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.